Star Health and Allied Insurance Company Limited (STARHEALTH) Q1 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

CompoundingAI Research Updated July 24, 2026 3 min read

Star Health and Allied Insurance enters the first quarter of FY 2026-2027 amid an industry-wide health insurance growth spurt of 18.5% in the early months of the quarter. Investors will be focused on whether the company can maintain its recent underwriting profitability improvements and how regulatory changes regarding senior citizen coverage impact its claims ratio trajectory.

Quick Details

Results date	July 29, 2026
Quarter	Q1 FY 2026-2027
Previous quarter revenue	Rs. 5,968.40 Cr
Previous quarter PAT	Rs. 111.33 Cr
Market cap	Rs. 34,316.99 Cr
CMP	Rs. 583.05

Star Health and Allied Insurance Company Limited Q1 Results Date and Time

The Board of Directors will meet on July 29, 2026, to consider the audited financial results and recommend dividend for FY 2026-2027.

What to expect from Star Health and Allied Insurance Company Limited's Q1 FY27 results

Star Health is well-positioned to capture a significant share of the 18.5% health insurance industry growth observed in April–May 2026, supported by its extensive semi-urban and rural agent network. While the company's incurred claim ratio of 69.55% in Q1 FY26 was higher than the 64.82% reported in Q4 FY26, the seasonal nature of the first quarter typically supports a lower claims incidence. Management's focus on portfolio rationalization and repricing is expected to keep the combined ratio in the 99-101% range, showing progress against the 102.16% combined ratio seen in the year-ago quarter. Investment income is expected to benefit from a tailwind of roughly 40-50 bps higher average yields compared to the year-ago quarter, though the expense of management ratio will likely remain elevated in the 32-33% band due to ongoing distribution and compliance costs.

Key Things To Watch

Claims and Expense Ratio Trajectory: Monitoring the impact of seasonal trends and regulatory compliance on core profitability metrics.

Claims ratio trend vs the 64.82% exit rate from Q4 FY26
Expense of management ratio maintenance vs the 32.25% FY26 level
Impact of new senior citizen product rollout on operating costs

Premium Growth and Market Share: Assessing Star Health's capture of the broader 18.5% health GDPI industry growth.

Growth composition across rural, semi-urban, and metro geographies
Performance of the agent-heavy distribution model in the current regulatory environment

Regulatory and Solvency Monitoring: Tracking capital adequacy and adherence to evolving IRDAI standards.

Solvency ratio stability vs the 2.05x level reported at FY26-end
Management commentary on medium-term combined ratio targets vs the FY26 100.42% result

Frequently Asked Questions

How did Star Health's underwriting profit perform in the same quarter last year?

In Q1 FY26, the company reported an underwriting profit of Rs. 71.72 Cr. This was achieved alongside a combined ratio of 102.16%.

What is the current regulatory status of the expense of management ratio?

The Expenses of Management Ratio was 32.25% for FY26. This remains within the regulatory ceiling of 35% set for standalone health insurers.

How does the current investment yield environment compare to the year-ago period?

The average 10-year G-sec yield during Q1 FY27 was approximately 40-50 bps higher than the yield environment during the Q1 FY26 period. This higher yield environment acts as a tailwind for the company's investment income.